NPR logo

Merck Ordered to Pay $4.5 Million in Vioxx Trial

  • Download
  • <iframe src="https://www.npr.org/player/embed/5326537/5326550" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Merck Ordered to Pay $4.5 Million in Vioxx Trial

Health

Merck Ordered to Pay $4.5 Million in Vioxx Trial

Merck Ordered to Pay $4.5 Million in Vioxx Trial

  • Download
  • <iframe src="https://www.npr.org/player/embed/5326537/5326550" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A New Jersey state court jury has awarded $4.5 million in a lawsuit filed by men who had suffered heart attacks while taking Vioxx, made by Merck & Co. The trial involved two plaintiffs, John McDarby, 77, and Thomas Cona, 60.

In its split decision, the jury said Vioxx was responsible only for McDarby's heart attack, not Cona's. Cona said he had taken the drug for 22 months, but he could only produce prescriptions that proved seven months of use. He said he used samples the rest of the time.

The award of $4.5 million to McDarby is for compensatory damages. On Thursday, the jury will decide whether Merck should face punitive damages as well.

The jury also found that, under New Jersey consumer-fraud law, Merck misrepresented Vioxx's risks when it marketed the drug to physicians. Merck is accused of intentionally suppressing or omitting material information about Vioxx's risks in its marketing to doctors.

Merck faces a class-action lawsuit in a case brought by a New Jersey labor union that provides health benefits to its members.

We no longer support commenting on NPR.org stories, but you can find us every day on Facebook, Twitter, email, and many other platforms. Learn more or contact us.